QA: Chemocentryx Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001340652_2019_Chemocentryx_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001340652, Chemocentryx Inc

  xvar xval
0 AssetsCurrent 181,384,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,536,000
3 remainder_Assets 390,000
4 LiabilitiesCurrent 64,396,000
5 LiabilitiesNoncurrent 20,076,000
6 remainder_Liabilities 84,100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,378,319
9 ResearchAndDevelopmentExpense 64,625,740
10 remainder_Expenses 0
11 remainder_Revenues 53,797,552
12 remainder_NetIncome 5,546,827
13 remainder_ComprehensiveNetIncome -75,551
  yvar yval
0 Assets 183,310,000
1 Liabilities 168,572,000
2 Expenses 86,004,059
3 Revenues 53,797,552
4 StockholdersEquity 14,738,000
5 NetIncome -26,659,680
6 ComprehensiveNetIncome -26,697,456
7 BaseVar 248,652,994
8 EconomicCapitalRatiobeforeLimitedLiability 0.0309
9 EconomicCapitalRatio 1.44

Edgar->Model Mapping

Feature Distribution

Change over Time